Ledger.Open graph →
SEC Form D · Amendment · filed June 9, 2021

Akston Biosciences Corp

Offering
$8.0M
Sold
$7.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BEVERLY, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Thomas M. Lancaster · BEVERLY, MAExec · DirectorTodd C. Zion · BEVERLY, MAExec · DirectorJames M. Herriman · BEVERLY, MAExecRobyn M. Davis · BEVERLY, MADirectorLovick E. Cannon · BEVERLY, MADirectorJohn Moragne · SAN FRANCISCO, CAExec · DirectorRoisin Addlestone · Grand Cayman, Cayman IslandsDirectorShahan Soghikian · SAN FRANCISCO, CAExecMichael Fordyce · SAN FRANCISCO, CADirectorChris Albinson · SAN FRANCISCO, CAExec · DirectorOliver B. Keller · Boston, MADirectorMary E. Alexander · Fayetteville, ARExecStephen C. Malloy · Fayetteville, ARExec · DirectorSSI Investment Management LLC · Beverly Hills, CADirectorDonald L. Hawks Iii · Stamford, CTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗